Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Scopus BioPharma Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 15 | 1 | −14 |
| Shares | 465.9K | 76.8K | −389.0K (−83.5%) |
| Value | $110.6K | $7.49K | −$103.2K (−93.2%) |
New holders (0)
Institutions that held Scopus BioPharma Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (14)
Institutions that held Scopus BioPharma Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Geode Capital Management, LLC | 217,078 | $52.0K |
| Renaissance Technologies LLC | 61,104 | $15.0K |
| Tower Research Capital LLC (TRC) | 26,533 | $6.00K |
| State Street Corp | 20,729 | $5.00K |
| Northern Trust Corp | 12,516 | $3.00K |
| First Manhattan Co | 13,100 | $3.00K |
| HRT Financial LP | 14,353 | $3.00K |
| Y-Intercept (Hong Kong) Ltd | 10,940 | $2.65K |
| JPMorgan Chase & Co | 5,000 | $1.00K |
| UBS Group AG | 2,254 | $1.00K |
| Compagnie Lombard Odier SCmA | 4,360 | $1.00K |
| Wells Fargo & Company | 69 | $0 |
| Harbour Investments, Inc. | 1,000 | $0 |
| Morgan Stanley | 2 | $0 |